Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 63

1.

[Myeloid sarcoma of nervous plexus - infiltration of the nerve plexus by extramedullary manifestation of acute myeloid leukemia].

Heckl S, Horger M, Faul C, Ebrahimi A, Ioanoviciu SD.

Rofo. 2014 Dec;186(12):1059-62. doi: 10.1055/s-0034-1369372. Epub 2014 Nov 25. German. No abstract available.

2.

Fluorescence imaging of human cells with a novel conjugate of the antifungal nystatin.

Sheikh S, Sturzu A, Kalbacher H, Nagele T, Weidenmaier C, Horger M, Ernemann U, Heckl S.

Med Chem. 2014 Jun;10(4):348-54.

PMID:
24725140
3.

Successful treatment of Erdheim-Chester disease with combination of interleukin-1-targeting drugs and high-dose glucocorticoids.

Darstein F, Kirschey S, Heckl S, Rahman F, Schwarting A, Schuchmann M, Galle PR, Zimmermann T.

Intern Med J. 2014 Jan;44(1):90-2. doi: 10.1111/imj.12329.

PMID:
24450524
4.

Dissociated language functions: a matter of atypical language lateralization or cerebral plasticity?

Acioly MA, Gharabaghi A, Zimmermann C, Erb M, Heckl S, Tatagiba M.

J Neurol Surg A Cent Eur Neurosurg. 2014 Jan;75(1):64-9. doi: 10.1055/s-0033-1358610. Epub 2013 Dec 19.

PMID:
24357070
5.

The gastrin/cholecystokinin-B receptor on prostate cells--a novel target for bifunctional prostate cancer imaging.

Sturzu A, Klose U, Sheikh S, Echner H, Kalbacher H, Deeg M, Nägele T, Schwentner C, Ernemann U, Heckl S.

Eur J Pharm Sci. 2014 Feb 14;52:69-76. doi: 10.1016/j.ejps.2013.10.013. Epub 2013 Nov 6.

PMID:
24211650
6.

[New WHO described CNS tumor entities].

Bender B, Beschorner R, Honegger J, Heckl S, Ernemann U, Horger M.

Rofo. 2013 Nov;185(11):1021-4. doi: 10.1055/s-0033-1346771. Epub 2013 Oct 22. German. No abstract available.

PMID:
24150766
7.

[Hypophysitis and its mimics - diagnostic imaging of hypophysitis and differential diagnosis].

Horger M, Honegger J, Beschorner R, Klumpp B, Heckl S, Ernemann U, Bender B.

Rofo. 2013 Sep;185(9):789-93. doi: 10.1055/s-0032-1319724. Epub 2013 Sep 2. Review. German. No abstract available.

PMID:
23999745
8.

Rhodamine-marked bombesin: a novel means for prostate cancer fluorescence imaging.

Sturzu A, Sheikh S, Echner H, Nägele T, Deeg M, Amin B, Schwentner C, Horger M, Ernemann U, Heckl S.

Invest New Drugs. 2014 Feb;32(1):37-46. doi: 10.1007/s10637-013-9975-2. Epub 2013 Jun 1.

PMID:
23728918
9.

Ramoplanin imaging conjugates--synthesis and evaluation.

Sheikh S, Sturzu A, Kalbacher H, Klose U, Nagele T, Amin B, Deeg M, Horger M, Ernemann U, Heckl S.

Med Chem. 2014;10(1):18-26.

PMID:
23646874
10.

Novel bourgeonal fragrance conjugates for the detection of prostate cancer.

Sturzu A, Sheikh S, Echner H, Nägele T, Deeg M, Schwentner C, Horger M, Ernemann U, Heckl S.

Invest New Drugs. 2013 Oct;31(5):1151-7. doi: 10.1007/s10637-013-9943-x. Epub 2013 Mar 19.

PMID:
23508273
11.

Imaging findings in tick-borne encephalitis with differential diagnostic considerations.

Horger M, Beck R, Fenchel M, Ernemann U, Nägele T, Brodoefel H, Heckl S.

AJR Am J Roentgenol. 2012 Aug;199(2):420-7. doi: 10.2214/AJR.11.7911. Review.

PMID:
22826407
12.

Common and uncommon imaging findings in progressive multifocal leukoencephalopathy (PML) with differential diagnostic considerations.

Horger M, Beschorner R, Beck R, Nägele T, Schulze M, Ernemann U, Heckl S.

Clin Neurol Neurosurg. 2012 Oct;114(8):1123-30. doi: 10.1016/j.clineuro.2012.06.018. Epub 2012 Jul 6. Review.

PMID:
22771304
13.

Evaluating the diagnostic and chemotherapeutic potential of vancomycin-derived imaging conjugates.

Sheikh S, Sturzu A, Klose U, Echner H, Deeg M, Nägele T, Horger M, Schwentner C, Ernemann U, Voelter W, Heckl S.

Med Chem. 2012 Nov;8(6):1163-70.

PMID:
22741805
14.

T2 and DWI in pilocytic and pilomyxoid astrocytoma with pathologic correlation.

Horger M, Vogel MN, Beschorner R, Ernemann U, Wörner J, Fenchel M, Ebner F, Nägele T, Heckl S.

Can J Neurol Sci. 2012 Jul;39(4):491-8.

PMID:
22728857
15.

Severe paraneoplastic hypereosinophilia in metastatic renal cell carcinoma.

Todenhöfer T, Wirths S, von Weyhern CH, Heckl S, Horger M, Hennenlotter J, Stenzl A, Kanz L, Schwentner C.

BMC Urol. 2012 Mar 21;12:7. doi: 10.1186/1471-2490-12-7.

16.

Novel gastrin receptor-directed contrast agents - potential in brain tumor magnetic resonance imaging.

Sturzu A, Sheikh S, Klose U, Deeg M, Echner H, Nagele T, Ernemann U, Heckl S.

Med Chem. 2012 Mar;8(2):133-7.

PMID:
22385171
17.

Potential of the gastric motility drug lorglumide in prostate cancer imaging.

Sturzu A, Sheikh S, Klose U, Echner H, Kalbacher H, Deeg M, Nägele T, Horger M, Schwentner C, Ernemann U, Heckl S.

Eur J Pharm Sci. 2012 Apr 11;45(5):575-80. doi: 10.1016/j.ejps.2011.12.011. Epub 2011 Dec 30.

PMID:
22226647
18.

[Intraoperative MRI (iMRI) in neurosurgery: a radiological point of view].

Heckl S, Feigl GC, Honegger J, Schumann M, Horger M, Tatagiba M, Ernemann U.

Rofo. 2012 Jan;184(1):1-5. doi: 10.1055/s-0031-1301004. Epub 2012 Jan 4. German. No abstract available.

PMID:
22218979
19.

Using the neurotransmitter serotonin to target imaging agents to glioblastoma cells.

Sturzu A, Sheikh S, Klose U, Echner H, Kalbacher H, Deeg M, Nägele T, Horger M, Ernemann U, Heckl S.

Invest New Drugs. 2012 Dec;30(6):2141-7. doi: 10.1007/s10637-011-9780-8.

PMID:
22212740
20.

A novel lily-of-the-valley fragrance contrast agent for magnetic resonance and fluorescence imaging of prostate cancer cells.

Sturzu A, Echner H, Klose U, Sheikh S, Nagele T, Schwentner C, Ernemann U, Heckl S.

Curr Pharm Biotechnol. 2012 Feb;13(2):373-7.

PMID:
22188439
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk